1
Clinical Trials associated with Anti-BCMA CAR-T (The Affiliated Hospital of Xuzhou Medical University) / RecruitingEarly Phase 1IIT An open single center single arm clinical study of through infusion of anti-BCMA CAR-T and anti-CD38 CAR-T therapy for relapsed and refractory multiply myeloma
Start Date28 Apr 2020 |
Sponsor / Collaborator- |
100 Clinical Results associated with Anti-BCMA CAR-T (The Affiliated Hospital of Xuzhou Medical University)
100 Translational Medicine associated with Anti-BCMA CAR-T (The Affiliated Hospital of Xuzhou Medical University)
100 Patents (Medical) associated with Anti-BCMA CAR-T (The Affiliated Hospital of Xuzhou Medical University)
100 Deals associated with Anti-BCMA CAR-T (The Affiliated Hospital of Xuzhou Medical University)